Wave Ventures

Solu is a Finnish company focused on transforming its industry through innovative technology and a distinctive approach. The organization is led by a team of accomplished founders, advisors, and shareholders, many of whom are recognized figures in the business landscape of Finland, having previously established successful enterprises. Solu's ambition is to redefine industry standards and practices, positioning itself as a key player in the evolving market.

Carbo Culture Oy, founded in 2016 and based in Helsinki, Finland, specializes in producing biochar from waste biomass by employing a carbon sequestration process that captures carbon dioxide from the atmosphere. The company transforms orchard waste into high-quality biochar using patented reactors, which serves various applications, including soil enhancement and contamination remediation. This biochar helps improve soil health by retaining water and nutrients, while also supporting beneficial microorganisms. Additionally, Carbo Culture's innovative approach generates renewable energy and contributes to the creation of significant carbon credits, promoting sustainable practices in agriculture and construction.

Quicksave Interactive is a chat game platform developing fun gaming-based chatting applications. It is on a mission to define the emerging gaming platform on social messaging apps. Its chat game platform leverages technology to help in making messaging applications more interactive by offering multiple games. Quicksave Interactive was founded in 2017 and is headquartered in Helsinki, Southern Finland.

Surgify is engaged in the development of an innovative technology aimed at enhancing bone surgery outcomes. This technology focuses on protecting proximal soft structures during surgical procedures, thereby minimizing the risk of complications such as bleeding, infections, and nerve injuries. By collaborating closely with the Neurosurgical Department of Helsinki University Central Hospital, Surgify ensures that its solutions are informed by the needs of clinicians. The company is currently preparing to commercialize its technology, with support from the Finnish Funding Agency for Innovation. Through its advancements, Surgify aims to reduce patient suffering and improve overall quality of life for individuals undergoing bone surgery.